2017 American Transplant Congress
Immunosuppressant Costs for Medicare Part D and Kidney Transplant Recipients Since the Introduction of Generic Formulations in an Incident Kidney Transplant Population.
Background: Substitution of generics (GEN) for brand name (BN) immunosuppressants (IS) has increased in kidney transplant recipients (KTR) since the introduction of GEN mycophenolate mofetil…2017 American Transplant Congress
Understanding the Role of Induction Agents in Older versus Younger Kidney Transplant Recipients.
Johns Hopkins University, Baltimore, MD
Background: There has been an increase in the number of older (over 65) KT recipients. Aging-related changes such as differences in immune senescence may influence…2017 American Transplant Congress
Using Basiliximab Does Not Increase De Novo DSA Incidence but Reduces Cytomegalovirus Infections and Neoplastic Complications in Non-Sensitized Kidney Transplant Patients.
Background. In kidney transplantation, de novo donor specific antibodies (dnDSA) are associated with antibody-mediated rejection (AMR) and graft failure. After dnDSA development, 24% of the…2017 American Transplant Congress
Endoscopic Therapy of Bile Duct Strictures After Liver Transplant.
Gastroenterolgy and Hepatology, Methodist Dallas Medical Center, Dallas, TX
Background and Aims: Common Bile Duct Strictures (CBDS) are a significant source of morbidity after liver transplantation (LT) We report our outcomes of endoscopic treatment…2017 American Transplant Congress
Extending the Limit for Living Donor Liver Transplantation: Similar Outcomes After Left vs. Right Lobe Graft, a Propensity Score Analysis.
Surgery, The University of Hong Kong, Hong Kong, Hong Kong
BackgroundThis study aimed to investigate the impact of graft selection (left vs. right lobe) in LDLT.MethodThis was a retrospective study that included all patients who…2017 American Transplant Congress
Kinetics of Liver regeneration in Donors After Living Donor Living Transplant.
Liver Transplant & HPB, Kokilaben Dhirubhai Ambani Hospital, Mumbai, Maharashtra, India
Introduction:The fundamental principle in LDLT lies in the fact that it should provide enough liver volume with a safe remnant.The main pretext for safe donor…2017 American Transplant Congress
Long-Term Analysis of Combined Liver-Lung Transplant Outcomes at a Single-Center.
1School of Medicine, Duke University, Durham, NC; 2Surgery, Duke University, Durham, NC
Purpose: Combined liver-lung transplantation (CLLT) is indicated in patients who would not be expected to survive transplantation of either organ alone. We present one of…2017 American Transplant Congress
Use of Biodegradable Stents for the Treatment of Anastomotic Biliary Strictures in Pediatric Liver Transplant Patients.
Objectives To evaluate feasibility, safety and mid-time outcome of pediatric liver transplant patients treated with a biodegradable biliary stent for anastomotic biliary strictures.Methods Retrospective study…2017 American Transplant Congress
Modular Training in Organ Procurement, in the Present Era of High BMI Donors: Validation by Results.
Multi Organ Transplant Unit, London Health Sciences Centre, London, ON, Canada
Back ground: Last year, we presented our improved quality care data of modular training program (step wise surgical training) for all abdominal organ procurements at…2017 American Transplant Congress
Recognition of Islet Xenografts In Vivo by Non-Obese Diabetic (NOD) Insulin-Specific CD4 T Cells.
Surgery and Immunology, University of Colorado Denver, Aurora, CO
Xenogeneic islet transplantation has been one ongoing goal for treating autoimmune Type 1 diabetes. Autoimmune diabetes involves a T cell response restricted to the host…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 181
- Next Page »